These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8541935)

  • 1. Divalproex sodium as a treatment for borderline personality disorder.
    Wilcox JA
    Ann Clin Psychiatry; 1995 Mar; 7(1):33-7. PubMed ID: 8541935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of borderline personality disorder with mood instability with divalproex sodium: series of ten cases.
    Townsend MH; Cambre KM; Barbee JG
    J Clin Psychopharmacol; 2001 Apr; 21(2):249-51. PubMed ID: 11270932
    [No Abstract]   [Full Text] [Related]  

  • 3. Divalproex sodium in the treatment of aggressive behavior.
    Wilcox J
    Ann Clin Psychiatry; 1994 Mar; 6(1):17-20. PubMed ID: 7951640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
    Hollander E; Allen A; Lopez RP; Bienstock CA; Grossman R; Siever LJ; Merkatz L; Stein DJ
    J Clin Psychiatry; 2001 Mar; 62(3):199-203. PubMed ID: 11305707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.
    Kavoussi RJ; Coccaro EF
    J Clin Psychiatry; 1998 Dec; 59(12):676-80. PubMed ID: 9921702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.
    Simeon D; Baker B; Chaplin W; Braun A; Hollander E
    CNS Spectr; 2007 Jun; 12(6):439-43. PubMed ID: 17545954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
    Redmond JR; Jamison KL; Bowden CL
    CNS Spectr; 2006 Dec; 11(12):915-8. PubMed ID: 17146405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
    Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
    Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of endogenous depressions with valpromide (open study).
    Svestka J; Rysánek R; Cesková E
    Homeost Health Dis; 1991; 33(5-6):291-2. PubMed ID: 18265503
    [No Abstract]   [Full Text] [Related]  

  • 12. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
    Davis LL; Bartolucci A; Petty F
    J Affect Disord; 2005 Apr; 85(3):259-66. PubMed ID: 15780695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of valproic acid in the treatment of borderline personality disorder].
    Hirschman S; Dolberg OT; Stern L; Grunhaus LJ
    Harefuah; 1997 Sep; 133(5-6):205-8. PubMed ID: 9461692
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy of divalproex sodium in the treatment of agitation associated with major depression.
    Debattista C; Solomon A; Arnow B; Kendrick E; Tilston J; Schatzberg AF
    J Clin Psychopharmacol; 2005 Oct; 25(5):476-9. PubMed ID: 16160625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mood stabilizer in the psychopharmacotherapy of borderline personality disorder].
    Gescher DM; Malevani J
    Fortschr Neurol Psychiatr; 2009 Jul; 77(7):389-98. PubMed ID: 19455483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended release.
    Minirth FB; Neal V
    J Clin Psychopharmacol; 2005 Feb; 25(1):99-101. PubMed ID: 15643111
    [No Abstract]   [Full Text] [Related]  

  • 17. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on pharmacotherapy of borderline personality disorder.
    Zanarini MC
    Curr Psychiatry Rep; 2004 Feb; 6(1):66-70. PubMed ID: 14738708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine and borderline personality disorder.
    Rizvi ST
    J Child Adolesc Psychopharmacol; 2002; 12(4):365-6. PubMed ID: 12625999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.